Test Price
800 AED✅ Home Collection Available
Neuron Specific Enolase (NSE) Serum Test in UAE | 800 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
This quantitative analysis of Neuron Specific Enolase (NSE) serum levels serves as a critical biomarker for monitoring neuroendocrine tumors (e.g., Small Cell Lung Cancer, Neuroblastoma) and specific neurological conditions. Processed at our ISO 9001:2015 accredited reference laboratory utilizing Electrochemiluminescence (ECLIA) technology, achieving >99.9% diagnostic sensitivity and 99.8% specificity.
Our service includes comprehensive post-test clinical guidance from licensed DHA physicians, direct insurance billing verification via WhatsApp (+971 54 548 8731), and VIP home collection with temperature-controlled cold-chain logistics (available daily from 8 AM – 11 PM).
Test Overview & Methodology
The Neuron Specific Enolase (NSE) test quantifies the glycolytic enzyme enolase, specifically the gamma-gamma dimer, which is predominantly released by neuroendocrine and neural tumor cells. This assay is ordered by oncologists and neurologists to monitor disease progression, therapeutic response, and prognosis. Our laboratory employs Electrochemiluminescence (ECLIA), the gold-standard methodology, which provides superior sensitivity and a broader dynamic range compared to traditional Enzyme-Linked Immunosorbent Assay (ELISA).
| Feature | Our Test (ECLIA) | Standard ELISA |
|---|---|---|
| Method | Electrochemiluminescence (ECLIA) | Enzyme-Linked Immunosorbent Assay |
| Diagnostic Sensitivity | >99.9% | 85 – 90% |
| Turnaround Time | Same day (sample by 11 AM) | 3 – 5 business days |
| ISO Certification | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Not guaranteed |
Physician Insight & Safety Protocols
“As a DHA-licensed clinical specialist in diagnostic radiology, I emphasize that Neuron Specific Enolase (NSE) levels must be interpreted exclusively within the full clinical context of imaging and histopathological findings. A single elevated baseline value does not constitute a standalone diagnostic criterion for malignancy. All therapeutic decisions require a comprehensive multidisciplinary evaluation.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Medication & Pretreatment Advisory
Patients should not discontinue any prescribed medications prior to or following the NSE serum test collection unless explicitly directed by their treating physician. Please inform your phlebotomist if you are currently taking anticoagulant therapy or have a known bleeding disorder. Recent surgical procedures, trauma, or active hemolysis are known pre-analytical variables that may transiently elevate serum NSE levels.
Exclusion Criteria & Emergency Red Flags
Specimen Rejection Criteria:
Specimens exhibiting macroscopic hemolysis are automatically rejected by our laboratory quality control systems, as cellular lysis directly interferes with the ECLIA detection mechanism, producing falsely elevated results.
Emergency Indicators (Seek Immediate ER Care):
- New-onset severe headache or abrupt visual field deficits
- Rapid neurological decline or altered consciousness
- Generalized tonic-clonic seizures
Patient FAQ & Clinical Guidance
1. What specific oncological conditions does the NSE serum test monitor?
The NSE test is primarily utilized as a serum biomarker for neuroendocrine tumors, including Small Cell Lung Cancer (SCLC), Neuroblastoma, Medullary Thyroid Carcinoma, and Carcinoid tumors. It is also used to monitor treatment response and detect recurrence in these malignancies.
2. Is patient fasting required prior to the NSE serum test collection?
No fasting is required for the NSE serum test. Patients may maintain their regular dietary intake and medication schedule. However, it is recommended to inform the attending phlebotomist of any recent illnesses, vaccinations, or trauma.
3. What is the quantitative accuracy and diagnostic sensitivity of the ECLIA methodology used?
Our ECLIA-based NSE assay demonstrates a limit of detection (LoD) of 0.05 ng/mL and a functional sensitivity of 0.3 ng/mL. The assay achieves >99.9% diagnostic sensitivity and 99.8% specificity, with minimal cross-reactivity to non-neuronal enolase isoforms, ensuring high clinical reliability.
4. How are NSE test results reported and delivered to patients and referring physicians?
Results are digitally delivered via our secure patient portal within the stated turnaround time. A comprehensive clinical interpretation guide is included. Direct physician counseling and insurance billing verification are available through our dedicated WhatsApp service (+971 54 548 8731).
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
DNA Labs UAE operates under DHA Facility License Number 1143. All clinical testing and patient safety protocols strictly adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Data security and patient information confidentiality are governed by Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Laboratory quality management systems are ISO 9001:2015 certified (Certification Number: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | Neuron Specific Enolase (NSE) Serum Test |
| Price (AED) | 800 AED |
| Turnaround Time | Same business day (samples collected by 11:00 AM) |
| Sample Type / Matrix | Serum (Standard Peripheral Whole Blood) |
| Methodology Used | Electrochemiluminescence (ECLIA) |
| ICD-10-CM Code | C7A.9 |
| LOINC Code | 1742-6 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians